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Summary
Mutations in RECQL4 helicase are associated with Rothmund–Thomson syndrome (RTS). A subset of RTS patients is predisposed to
cancer and is sensitive to DNA damaging agents. The enhanced sensitivity of cells from RTS patients correlates with the accumulation
of transcriptionally active nuclear p53. We found that in untreated normal human cells these two nuclear proteins, p53 and RECQL4,
instead colocalize in the mitochondrial nucleoids. RECQL4 accumulates in mitochondria in all phases of the cell cycle except S phase
and physically interacts with p53 only in the absence of DNA damage. p53–RECQL4 binding leads to the masking of the nuclear
localization signal of p53. The N-terminal 84 amino acids of RECQL4 contain a mitochondrial localization signal, which causes the
localization of RECQL4–p53 complex to the mitochondria. RECQL4–p53 interaction is disrupted after stress, allowing p53
translocation to the nucleus. In untreated normal cells RECQL4 optimizes de novo replication of mtDNA, which is consequently
decreased in fibroblasts from RTS patients. Wild-type RECQL4-complemented RTS cells show relocalization of both RECQL4 and p53
to the mitochondria, loss of p53 activation, restoration of de novo mtDNA replication and resistance to different types of DNA damage.
In cells expressing D84 RECQL4, which cannot translocate to mitochondria, all the above functions are compromised. The recruitment
of p53 to the sites of de novo mtDNA replication is also regulated by RECQL4. Thus these findings elucidate the mechanism by which
p53 is regulated by RECQL4 in unstressed normal cells and also delineates the mitochondrial functions of the helicase.
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Introduction
BLM helicase (BLM), Werner helicase (WRN) and RECQL4
helicase are members of the evolutionarily conserved RecQ
family of DNA helicases. Mutations in BLM and WRN genes
result in autosomal recessive cancer predisposition disorders
namely Bloom syndrome (BS) and Werner syndrome (WS),
respectively. Mutations in RECQL4 cause three autosomal
recessive disorders – Rothmund–Thomson syndrome type II
(RTS type II), RAPADILINO syndrome and some cases of
Baller–Gerold syndrome (BGS) (Bachrati and Hickson, 2008;
Ouyang et al., 2008). RTS type II is characterized by congenital
skeletal abnormalities, signs of premature aging and cancer
predisposition, especially to osteosarcoma (Siitonen et al., 2009).
The RECQL4 gene encodes a protein of 1208 amino acids with a
centrally conserved helicase domain. The N-terminal region of
RECQL4 has been implicated in the initiation of nuclear DNA
replication. RECQL4 functions in prereplication complex
formation (Sangrithi et al., 2005) and is required for chromatin
binding of DNA polymerase a during initiation of DNA
replication (Matsuno et al., 2006). Recently it has been
reported that two distinct domains of RECQL4, the conserved
helicase motifs and the N-terminal Sld2-like domain, could
independently exhibit helicase activity (Xu and Liu, 2009). Using
transfection-based experiments, RECQL4 was characterized as a
nuclear protein (Kitao et al., 1999a), consisting of a nuclear
localization signal (NLS) encompassing amino acids 363–492 in
RECQL4 (Burks et al., 2007). However, using antibodies against
endogenous RECQL4, the protein was shown to have a
cytoplasmic localization (Petkovic et al., 2005; Werner et al.,
2006; Yin et al., 2004).
Tumor suppressor p53 is arguably the most studied tumor
suppressor because of its role as a sequence-dependent
transcription factor in the nucleus, thereby affecting many
cellular processes including cell cycle arrest, apoptosis, aging
and senescence in response to variety of stress (reviewed by
Riley et al., 2008; Vousden and Lane, 2007). However, in recent
years the role of p53 in cytoplasm especially during autophagy,
energy metabolism and mitochondrial functions (reviewed by
Galluzzi et al., 2011; Green and Kroemer, 2009) have also come
into sharper focus.
It has been demonstrated that p53 physically and functionally
interacts with either BLM or WRN (Blander et al., 1999;
Garkavtsev et al., 2001; Guay et al., 2006; Yang et al., 2002) and
attenuates their helicase activities in vitro (Sommers et al., 2005;
Yang et al., 2002). Reciprocally, BLM and WRN cooperate with
p53, and are involved in the modulation of p53 functions
Research Article 2509
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
(Blander et al., 2000; Garkavtsev et al., 2001). Endogenous BLM
binds with Ser15-phosphorylated p53 in the presence of DNA
damage (Restle et al., 2005; Sengupta et al., 2003). BLM is
required for the localization of p53 to the sites of damage and the
two factors together regulate homologous recombination
(Sengupta et al., 2003). Both WS and BS cells show attenuated
p53-dependent apoptosis (Spillare et al., 1999; Wang et al.,
2001), which can be complemented by microinjection of WRN
and BLM cDNA (Spillare et al., 2006).
We had earlier reported that tumor suppressor p53 attenuates
the expression of RECQL4 during DNA damage by repressing
its promoter activity (Sengupta et al., 2005). Repression of
the RECQL4 promoter was accompanied by an increased
accumulation of HDAC1, and simultaneous the loss of SP1 and
p53 binding to the promoter. We here provide evidence that the
enhanced sensitivity observed in the cells of RTS patients
correlates with the accumulation of transcriptionally active p53 in
the nucleus. We report, for the first time, that endogenous
RECQL4 predominantly localizes to the mitochondria by
utilizing a mitochondrial localization signal (MLS) located in
its N-terminal 84 amino acids. In wild-type untreated human cells
RECQL4 relocates p53 to the mitochondrial nucleoids, thereby
preventing the accumulation of active p53 in the nucleus and,
consequently, its function as a transcription factor. In the
mitochondrial nucleoids, RECQL4 itself regulates mitochondrial
DNA (mtDNA) replication and also the localization of p53 to the
sites of de novo mtDNA synthesis. Altogether, we hypothesize that
the localization of RECQL4 in mitochondria might account for
some of the phenotypic features in RTS patients.
Results
Enhanced sensitivity of cells of RTS patients to genotoxic
drugs correlates with the accumulation of transcriptionally
active nuclear p53
It has been reported that the cells of RTS patients (hereafter
referred to as RTS cells) are sensitive to many genotoxic agents
(Jin et al., 2008; Werner et al., 2006). To confirm the earlier
reports, long-term clonogenic assays were carried out after
exposure of RTS cells and normal human fibroblasts (NHFs) to
four different inducers of DNA damage, namely: camptothecin
(Camp; a topoisomerase I inhibitor), neocarzinostatin (NCS; an
inducer of double strand breaks), mitomycin C (Mito; a potent
DNA crosslinker) and hydroxyurea (HU; causes replication stress).
Indeed, the survival of all tested RTS cells in the long-term
clonogenic assays was significantly less than the survival of NHFs
following many types DNA damage (supplementary material Fig.
S1A). To understand the molecular basis of the enhanced
sensitivity of the RTS cells to DNA damage, levels of p53 were
analyzed in untreated cells and in cells exposed to the DNA
damage inducers. Compared with NHFs, RTS cells, when treated
with DNA damage inducers, had enhanced levels of
transcriptionally active p53, along with induction of its
transcriptional targets p21 (encoded by the gene CDKN1A) and
Bax (Fig. 1A,B; supplementary material Fig. S2). The presence of
transcriptionally active p53 was observed for all the RTS
fibroblasts except L9552914-J, which expresses mutant p53
(Fig. 1A, and see Materials and Methods section).
Transcriptionally active p53 was also observed in untreated RTS
cells (Fig. 1A,B, compare lanes for NHFs and RTS cells without
DNA damage; supplementary material Fig. S2). The increase in
the basal level of transcriptionally active nuclear p53 [carried out
with p53 antibody, sc-126 (DO-1)] was also substantiated by
immunofluorescence analysis (at 406magnification) in untreated
cultures of RTS cells and not in NHFs (Fig. 1C).
p21 and Bax are known to be upregulated by both p53-dependent
and -independent mechanisms (Michieli et al., 1994; Strobel et al.,
1996). Hence, we wanted to verify whether nuclear p53 in RTS
fibroblasts could upregulate its other known targets. Apart from p21
and Bax, other targets of p53 (such as MDM2 and PUMA) were
also upregulated in all the RTS cell types tested that expressed wild-
type p53: i.e. AG03587, AG05013, B1865425K and D8903644-K
(Fig. 1D, and data not shown). Transcriptionally active p53 is also
characterized by specific phosphorylation events at N-terminal
serine residues of p53, including Ser15 and Ser46 (Xu, 2003). The
stabilized p53 in the RTS cells was phosphorylated at Ser15 and
Ser46 (Fig. 1D, and data not shown). In untreated NHF cells there
was complete absence of p53 phosphorylation at Ser15 and Ser46.
To further validate that the upregulation of p21 and Bax in RTS
cells was a p53-dependent effect, p53 siRNA (or siRNA control)
was transfected into RTS cells. The increase in the level of p21 and
Bax observed in AG05013 was not observed in cells expressing p53
siRNA (Fig. 1E). To determine whether absence of only RECQL4
was sufficient to cause activation of nuclear p53, we transiently
silenced RECQL4 expression in NHF cells by its cognate short
interfering RNA (siRNA; Fig. 1F) or stably depleted its expression
by use of RECQL4 short hairpin RNA (shRNA; Fig. 1G). In both
cases upregulation of p53 and its cellular targets (p21, Bax,
MDM2 and PUMA) was observed in fibroblasts in which
RECQL4 expression was depleted. The stabilized p53 was also
phosphorylated at the N-terminal serine residues (Ser15 and Ser46).
These phenomena were observed by both western analysis
(Fig. 1F,H, and data not shown) and immunofluorescence
experiments (data not shown).
Next we wanted to determine the reason for the p53
phosphorylation and stabilization in the nucleus of untreated
RTS cells. Untreated NHFs and three different RTS fibroblasts
were fixed and stained for 53BP1, a DNA damage sensor protein
known to respond to different types of DNA damage (Schultz
et al., 2000). Untreated NHFs had very few 53BP1 foci. The
number of 53BP1 foci was reproducibly higher in the tested RTS
fibroblasts (supplementary material Fig. S3A), indicating the
accumulation of spontaneous DNA damage in RTS cells. This
was further validated when more 53BP1 foci were observed in
untreated NHF shRECQL4 cells compared with NHF shControl
cells (supplementary material Fig. S3B). The spontaneous DNA
damage in cells not expressing RECQL4 was probably
recognized by the sensory kinases ATM and ATR, which in
turn phosphorylated p53 at Ser15 and Ser46 leading to activation
and stabilization of p53 in these cell lines (supplementary
material Fig. S3C). The presence of N-acetylcysteine, a potent
anti-oxidant and reactive oxygen species (ROS) scavenger, did
not lead to any loss of p53 activation, indicating that
mitochondrial stress is possibly not the only reason for
spontaneous DNA damage in the nucleus of RTS cells.
RECQL4 and p53 colocalize in mitochondria
p53 had exclusively nuclear localization in approximately 5–10%
of NHFs and 80–90% of RTS fibroblasts when examined at low
(406) magnification (Fig. 1C) with sc-126 antibody (which
recognizes an epitope in the N-terminal region of p53). The same
experiment was also done in parallel but stained with SIG-3250-
1000 (which recognizes the entire p53 protein without any
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Fig. 1. Lack of RECQL4 leads to the accumulation of transcriptionally active nuclear p53. (A,B) Basal and drug-induced levels of p53 are elevated in RTS
cells. NHFs and RTS cells were left untreated or treated with either camptothecin (Camp; A) or neocarzinostatin (NCS; B) for 1 hour or 6 hours and whole cell
lysates prepared. Westerns blots were carried out with RECQL4 (K6312), p53 (sc-126), p21 and Bax antibodies. Coomassie Blue gels (at the bottom) were used
for equalization. (C) Nuclear p53 is elevated in untreated RTS cells. Immunofluorescence analysis (IFs) on NHFs or RTS cells with p53 (sc-126) and p21
antibodies. Nuclei were stained with DAPI. Cells were examined using epifluorescence microscope at 406magnification. The percentage of cells with p53–p21
colocalization is indicated at the bottom right of each panel. Scale bar: 5 mm. (D) In RTS cells N-terminal serine residues of p53 are phosphorylated. The cells
were treated as in A and B except that only untreated NHFs and AG03587 were used to prepare the whole cell lysates. Western blotting was carried out with
RECQL4 (K6312), p53 (sc-126), phosphorylated p53 Ser15, phosphorylated p53 Ser46, MDM2 and hsp90 antibodies. (E) p53-dependent increase in the level of
p21 and Bax in AG05013 cells. NHFs and AG05013 cells were transfected with either control siRNA or RECQL4 siRNA. Whole cell lysates were probed with
p53 (sc-126), p21, Bax and hsp90 antibodies. (F–H) Transcriptionally active nuclear p53 is present in cells with depleted RECQL4. NHFs were transfected with
either a control siRNA or RECQL4 siRNA for 48 hours (F). Alternately NHFs were stably transfected with either control shRNA or shRECQL4 (G). NHF
shControl or NHF shRECQL4 cells were either left untreated or treated with NCS for 1 hour or 6 hours (H). The protein levels in the whole cell lysates were
detected by western blot analysis with RECQL4 (K6312), p53 (sc-126), p21, Bax, phosphorylated p53 Ser15 and hsp90 antibodies. The Coomassie Blue gel at the
bottom of H was used for equalization.
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detectable cross reactivity in NHFs as observed by both western
analysis and immunofluorescence (supplementary material Fig.
S4A,B) and examined at a higher magnification with oil
immersion (636 or 1006) and epifluorescence microscopy.
This process revealed that in the 80–90% of NHFs p53
localization was cytoplasmic, and it colocalized with
Mitotracker Red. However, the localization of p53 (as detected
by SIG-3250-1000) in RTS cells, was predominantly nuclear
(Fig. 2A), though some cytoplasmic p53 was still observed. To
examine the subcellular distribution of endogenous p53 and
RECQL4 in more detail, untreated NHFs were co-stained with
RECQL4 and p53 antibodies and examined by confocal
microscopy. Specific punctate cytoplasmic p53 staining was
observed (Fig. 2B). This staining pattern was verified using
several fixation procedures, in two other primary fibroblast
cultures (GM08402 and MRC-5; supplementary material Fig.
S5A) and by loss of staining in NHF E6 cells (constitutively
expressing HPV E6 oncoprotein, which degrades endogenous
p53; data not shown). Incidentally the punctate cytoplasmic
staining of p53 was not observed in transformed cell lines, e.g.
HCT116 (data not shown).
Two different antibodies (the specificities are shown in
supplementary material Fig. S4C,D) were used to determine
RECQL4 localization. Similar to p53, RECQL4 staining was also
punctate in the cytoplasm of untreated NHFs, and it colocalized
with p53 (Fig. 2B). Again this staining pattern was verified in
other primary human fibroblasts (GM08402 and MRC-5;
supplementary material Fig. S5A) but was not observed in
transformed cell lines (HCT116, MCF7) with several fixation
processes (data not shown). We then investigated whether the
cytoplasmic localization of p53 and RECQL4 was mitochondrial,
as indicated by their punctate pattern. Subcellular fractionation
identified a substantial amount of RECQL4 and p53 in the
mitochondrial fraction (Fig. 2C). Furthermore, we found that
both p53 and RECQL4 colocalized extensively with the
mitochondrial marker, cytochrome c (Fig. 2D,E). Incidentally
both p53 and RECQL4 localized predominantly at the
mitochondrial nucleoids, the storehouse of mtDNA (enlarged
images in Fig. 2D,E). Both p53 and RECQL4 also colocalized at
the sites of mtDNA synthesis during BrdU labeling experiments
(Fig. 2F; supplementary material Fig. S5B,C).
Interaction between RECQL4 and p53
The localization of both p53 and RECQL4 in the mitochondrial
nucleoids suggests that the two proteins physically interact. To
determine whether this occurs, we carried out in vitro GST pull-
down assays. The minimal region of p53 that interacted with
RECQL4 in a nucleic-acid-independent manner encompassed
amino acids 293–362 [spanning NLS1 and the tetramerization
domain (TD) of p53] (supplementary material Fig. S6).
Reciprocally the N-terminal 459 amino acids of RECQL4
interacted with p53 (supplementary material Fig. S7A,D).
Using N- and C-terminal mutations within the first 459 amino
acids, an internal stretch of 130 amino acids (270–400) of
RECQL4 was considered to be the minimal region of interaction
(supplementary material Fig. S7A,D,F). This region in RECQL4
partially overlaps with its predicted NLS, which spans amino
acids 363–492 (Burks et al., 2007). Together the results suggest
that the interaction between p53 and RECQL4 leads to the
masking of their respective NLSs (summarized in Fig. 3A). The
interaction of RECQL4 (270–400) with p53 was verified either
by using a GST-tagged RECQL4 (270–400) fragment in vitro
(supplementary material Fig. S7G,H) or by using a FLAG-tagged
RECQL4 (1–459) fragment in vivo (supplementary material Fig.
S8A). The full-length RECQL4 but not the N-terminal 404-
amino-acid-truncated variant interacted with GFP-tagged full-
length p53 (supplementary material Fig. S8B). The interaction
between p53 and RECQL4 was limited to the untreated NHFs.
Exposure of NHFs to different agents that cause DNA damage,
such as camptothecin, etoposide and neocarzinostatin led to the
loss of p53–RECQL4 interaction (supplementary material Fig.
S8C, and data not shown) and instead both proteins accumulated
in the nucleus (supplementary material Fig. S8D,E, and data not
shown). The extent of p53–RECQL4 colocalization in the
mitochondrial nucleoid decreased in a time-dependent manner
(supplementary material Fig. S8F). Hence these experiments
indicate that in untreated cells localization of both p53 and
RECQL4 in the mitochondria could be due to their physical
interactions, which in turn could mask their NLS.
Loss of mtDNA inhibits localization of RECQL4 and p53
in mitochondria
Next we investigated the parameters that regulate the localization
of RECQL4 and p53 to the mitochondria. Using NHF E6 cells,
the localization of RECQL4 with mtDNA was determined to be
independent of p53 (supplementary material Fig. S9A, left). The
level of RECQL4 was increased in the absence of p53
(supplementary material Fig. S9A, right), possibly because of
the lack of p53-mediated repression of RECQL4 transcription
(Sengupta et al., 2005).
To determine whether mtDNA was required for the
localization of RECQL4 in the mitochondria, we created
transient NHF r0 cells, which were completely depleted of
mtDNA, as determined by the absence of cytochrome b gene
expression (supplementary material Fig. S9B). Compared with
NHFs, NHF r0 cells had less RECQL4 protein (supplementary
material Fig. S9C). The residual RECQL4 and p53 accumulated
in the nucleus of NHF r0 cells (Fig. 3B,C). The nuclear p53 in
NHF r0 cells was phosphorylated in the N-terminus and
transcriptionally active, thereby upregulating its downstream
targets, such as p21, Bax and MDM2 (supplementary material
Fig. S9C). Spontaneous DNA damage also occurred in the
nucleus of NHF r0 cells as indicated by the accumulation of
53BP1 foci (data not shown). These results indicate that the
presence of mtDNA is an essential requirement for RECQL4 and
p53 to accumulate in the mitochondrial nucleoids in untreated
cells.
Next we wanted to determine whether the accumulation of p53
and RECQL4 in the mitochondria was due to the shuttling of the
two proteins out of nucleus. Hence we stained RECQL4 and p53
either together (Fig. 3D) or individually with a mitochondrial
protein marker PolcA (supplementary material Fig. S9D).
Detection of PolcA was carried out with a validated antibody
(supplementary material Fig. S4E) in both untreated cultures and
in cultures treated with the nuclear export inhibitor, leptomycin
B. Although p53 localized to the nucleus after leptomycin B
treatment, a substantial fraction of p53 still colocalized with
RECQL4 in mitochondrial nucleoids. RECQL4 was not present
in the nucleus but was in mitochondria in untreated cells and cell
treated with leptomycin B (Fig. 3D; supplementary material Fig.
S9D). Hence these experiments suggest the presence of two pools
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Fig. 2. RECQL4 and p53 localize to the mitochondria. (A) Localization of p53 is predominantly nuclear in untreated RTS cell lines. NHFs and the indicated
RTS cell lines were stained with Mitotracker Red and for p53 (SIG-3520-1000) and examined using epifluorescence microscopy with a1006oil immersion lens.
(B,D,E) p53 and RECQL4 localize to mitochondria. Colocalization of p53 and RECQL4 in NHFs (B). Colocalization of p53 (D) or RECQL4 (E) with cytochrome
c. RECQL4 and p53 were stained with K6312 and SIG-3520-1000, respectively. Nuclei were stained with DAPI. Percentages of cells showing the colocalizaton of
p53 and RECQL4 (in B), p53 and cytochrome c (in D), RECQL4 and cytochrome c (in E) are indicated in the combined images. Scale bars: 5 mm. (C) Subcellular
fractionation reveals the localization of RECQL4 in mitochondria. 53BP1, hsp90 and Bcl2 were used as controls for nuclear, cytoplasmic (Cyto) and
mitochondrial (Mito) fractions, respectively. Antibodies used were: RECQL4 (K6312), p53 (sc-126), Bcl2, hsp90 and 53BP1. 600 mg of the respective fractions
were used. (F) p53, RECQL4 and BrdU colocalize with mtDNA in NHFs. NHFs, after incubation with BrdU for 3 hours, were stained with p53 (SIG-3520-1000),
RECQL4 (sc-16924) and BrdU (RPN202) antibodies. Percentage of cells having BrdU–p53–RECQL4 triple colocalizaton is indicated. Scale bar: 5 mm.
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of endogenous p53 in untreated cells: one p53 fraction that was
targeted to the mitochondria bound to RECQL4, and another
fraction that utilized its NLS and was transported to the nucleus,
where it was retained as a result of the leptomycin B treatment.
However, it has been reported that RECQL4 is also a nuclear
protein (Burks et al., 2007). Hence the possibility exists that the
subcellular localization of RECQL4 was cell-cycle dependent.
Using synchronized cell populations (after double thymidine
block; supplementary material Fig. S10A) we found that
RECQL4 colocalized with the catalytic subunit of
mitochondrial DNA polymerase, PolcA, in all phases of the
cell cycle (Fig. 3E). The punctate mitochondrial staining for
RECQL4 was observed 6 hours and 9 hours after the release of
the second thymidine block, indicating its accumulation in
mitochondrial nucleoids in late S and G2 phases of the cell cycle.
During S phase (3 hours after release) RECQL4 was present
predominantly in the nucleus, and it colocalized with PCNA
(supplementary material Fig. S10B), confirming the role of
RECQL4 in the initiation of nuclear replication (Matsuno et al.,
2006; Sangrithi et al., 2005).
Fig. 3. Parameters regulating the localization of RECQL4 and p53 to the mitochondria. (A) Summary of the physical interaction between p53 and RECQL4.
(Top) Schematic diagram showing the different domains of p53. The p53 NLS and the minimum region of p53 deduced to interact with RECQL4 from
(supplementary material Fig. S6) is shown. (Bottom) Schematic diagram showing the different domains of RECQL4. The RECQL4 NLS and the minimum region
of RECQL4 deduced to interact with p53 (supplementary material Fig. S7) is shown. (B,C). Localization of RECQL4 and p53 in the mitochondria depends on
mtDNA. IF in NHF and NHF r0 cells with (B) RECQL4 (sc-16924) or (C) p53 (SIG-3520-1000) antibodies. Mitochondria were visualized using Mitotracker Red
CMXRos. Scale bar: 5 mm. (D) RECQL4 and a fraction of p53 colocalize in mitochondrial nucleoids in the presence of leptomycin B. NHFs were either left
untreated or treated with leptomycin B. Staining was carried out with antibodies against RECQL4 (sc-16924) and p53 (SIG-3520–1000). Nuclei were stained with
DAPI. Numbers indicate the percentage of cells showing colocalization of RECQL4 and p53. Scale bar: 5 mm. (E) RECQL4 shuttles between the nucleus and the
mitochondria during the cell cycle. Cells were stained with RECQL4 (sc-16924) and PolcA (sc-48815) antibodies, immediately after release from double
thymidine block (0 hours) and after 3 hours, 6 hours, 9 hours and 12 hours. Nuclei were stained with DAPI. The percentage of cells showing RECQL4–PolcA
colocalization is indicated. Scale bar: 5 mm.
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RECQL4 has a functional mitochondrial localization signal
We next wanted to determine how RECQL4 and p53 were
localized to the mitochondria. To date, efforts to identify the
mitochondrial targeting signal in p53 have failed. Four web-
based tools: Target P, PSORT, MitoProt and iPSORT predicted
with high probability an MLS for RECQL4 in the N-terminal
domain (supplementary material Table S1). However, no MLS
was predicted for p53 (data not shown).
We hypothesized that for RECQL4 to localize to the
mitochondria, it has to physically interact with the TOM40
receptor complex located on the outer mitochondrial membrane
of human cells. Members of the TOM40 complex (Tom20,
Tom22, Tom70), recognize the N-terminal targeting signal
sequences of proteins destined for mitochondria (Chacinska et
al., 2009). Tom20 is the major import receptor (Pfanner, 2000),
which is anchored in the outer mitochondrial membrane, thereby
exposing its evolutionarily conserved C-terminal receptor domain
to the cytosol. We found that RECQL4 interacted in vitro with
the cytosolic part of the Tom20 receptor (Fig. 4A,B). Hence we
hypothesized that RECQL4 probably has a specific MLS in the
N-terminus that allowed it to interact with Tom20 receptor. A
systematic analysis with the disulfide-tethering peptide library
had previously revealed the amino acid residues of the substrates
involved in the interaction with Tom20 (Obita et al., 2003). The
hypothesized motif was s W x b W W x where W denotes a
hydrophobic, s, a hydrophilic, b a basic and x any amino acid.
We searched the N-terminal 100 amino acids of RECQL4 using
the above motif. Interestingly, one sequence stretch
A13WERAF18 of RECQL4 matched with the defined motif
(Fig. 4C). No sequence with the defined motif was found in p53
(data not shown). Hence, it was hypothesized that the majority of
p53 localized to mitochondria when it physically interacted with
RECQL4.
To obtain in vivo validation of the predicted MLS of RECQL4
we generated two deletion mutants of FLAG-tagged RECQL4:
D13–18 and D84. The D84 RECQL4 mutant was generated to
determine whether any other sequence in the extreme N-terminus
of RECQL4 apart from amino acids 13–18 was also required for
interaction with Tom20 and the subsequent mitochondrial
localization of RECQL4. We found that although there was a
reproducible 15–20% decrease in the binding between RECQL4
and Tom20 in the D13–18 mutant, the binding was almost
completely abolished in the D84 mutant (Fig. 4D). Hence
additional amino acid residues in the N-terminus of RECQL4
apart from residues 13–18 were probably required for Tom20–
RECQL4 interaction. To further verify the MLS, wild-type
FLAG–RECQL4 (1–1208), FLAG–RECQL4 (D13–18) or
FLAG–RECQL4 (D84) was transiently expressed in the human
TERT immortalized RTS patient cell line AG05013 (Kitao et al.,
1999b). FLAG-tagged wild-type RECQL4 appeared as punctate
staining outside the nucleus and also within the nucleus itself.
Both D13–18 and D84 RECQL4 mutants, however, localized
predominantly to the nucleus (Fig. 4E, top). The efficiency of
nuclear localization was higher for the D84 RECQL4 mutant
thereby validating the in vitro results in vivo. However, the
nuclear and mitochondria localization of the transfected wild-
type RECQL4 was different from the endogenous RECQL4 that
localizes predominantly to the mitochondria (Fig. 2B,D,F). This
is probably because of the higher expression level of FLAG–
RECQL4 (1–1208) during transient transfection than the
endogenous level in NHFs (Fig. 4E, bottom right). For further
validation, RECQL4 (13–18) was fused in frame with EGFP and
expressed transiently in AG05013 cells (Fig. 4F). EGFP alone
was homogeneously expressed in both nucleus and cytoplasm,
whereas EGFP–RECQL4 (13–18) had a punctate pattern that
colocalized with Mitotracker Red in a majority of the transfected
cells. Together, the results indicate that RECQL4 has a functional
MLS that dictates its own localization and consequently leads to
the localization of p53 in the mitochondria.
Rescue of RTS fibroblasts by expression of RECQL4
Having established how RECQL4 and p53 are localized to the
mitochondria in untreated normal human cells, we hypothesized
that the transcriptionally active nuclear p53 observed in cells of
RTS patients (Fig. 1) could be relocated back to the mitochondria
by stably overexpressing wild-type RECQL4. Hence we rescued
AG05013 cells with AcGFP–RECQL4 (1–1208) to generate
AG05013 AcGFP–RECQL4 (1–1208) clone 1. Very few
AG05013 AcGFP–RECQL4 (1–1208) clone 1 cells had
spontaneous 53BP1 foci (supplementary material Fig. S3A).
AcGFP–RECQL4 localized to mitochondria, as it colocalized
with Mitotracker Red (Fig. 5A). In contrast to the parental
AG05013 cells, p53 colocalized with AcGFP–RECQL4 in the
mitochondrial nucleoids of AG05013 AcGFP–RECQL4 clone 1
cells (Fig. 5B), thereby proving that accumulation of p53 on the
mitochondria in untreated cells depended on RECQL4. In
untreated AG05013 AcGFP–RECQL4 (1–1208) clone 1 cells a
decrease in the level of endogenous p53 was observed. The levels
of p53 targets (p21, Bax, PUMA and MDM2) and the N-terminal
phosphorylation of p53 at Ser15 and Ser46 were also decreased
(Fig. 5C, and data not shown). Using immunofluorescence, the
high level of transcriptionally active nuclear p53 observed in
untreated AG05013 cells was found to be reduced in AG05013
AcGFP–RECQL4 clone 1 cells (Fig. 5D, and data not shown).
Clonogenic assays carried out on AG05013 and AG05013
AcGFP–RECQL4 (1–1208) clone 1 cells after exposure to
camptothecin and neocarzinostatin indicated that the
hypersensitivity of RTS fibroblasts could be rescued by the re-
expression of wild-type RECQL4 (supplementary material Fig.
S1B). In summary, endogenous RECQL4 relocates p53 to the
mitochondria in normal untreated cells, thereby preventing its
nuclear activation in the absence of exogenous DNA damage.
RECQL4 is required for optimal de novo mtDNA replication
RECQL4 has been implicated in the regulation of nuclear
replication during S phase (Matsuno et al., 2006; Sangrithi et al.,
2005; Xu et al., 2009). Hence a probable role of RECQL4 in
mitochondria could be to regulate mtDNA replication. To
determine whether mtDNA replication in NHFs would only be
altered as a result of loss of RECQL4 expression, Southwestern
analysis with anti-BrdU antibody was carried out in control cells
and in cells that lack RECQL4. There was an approximately 50%
decrease in the mtDNA replication in shRECQL4 NHFs
compared with NHF shControl cells (Fig. 6A). These
observations were further validated by the decreased
incorporation of BrdU in all RTS fibroblasts (AG05013,
AG03587, B1865425K and D8903644-K) expressing wild-type
p53 (Fig. 6B, and data not shown).
To investigate whether RECQL4 affects mtDNA replication,
we scored for de novo mtDNA replication in isogenic control r
cells (NHF shControl r) and in RECQL4-depleted r cells (NHF
shRECQL4 r). Cells were grown in ethidium bromide, uridine
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and pyruvate (see Materials and Methods) to generate the r cells.
Subsequently ethidium bromide was washed away and the cells
were grown in normal medium containing BrdU for specific
intervals. Colocalization of BrdU with PolcA was scored at an
early (10 minutes) time point to determine the effect on the
initiation of mtDNA replication. Subsequently the effect on the
elongation stage during mtDNA replication was scored by
determining the colocalization after 30 minutes and 60 minutes.
Lack of RECQL4 in NHF shRECQL4 cells decreased BrdU–
PolcA colocalization at all time points (Fig. 6C,D), indicating
that RECQL4 is involved in the regulation of both initiation and
elongation steps of mtDNA replication. AG03587 r cells also
Fig. 4. RECQL4 has a functional MLS in its N-terminus. (A) Coomassie Blue gels showing purified GST and GST–rat Tom20 (59–126). (B) RECQL4
interacts with Tom20. Interactions carried out between [S35]methionine-labeled in vitro translated RECQL4 and either bound GST or GST-tagged rat Tom20 (59–
126). After washing, the bound radioactivity was visualized by autoradiography. (C) Predicted pre-sequence peptide in RECQL4 (residues 13–19). The
corresponding hexamer consensus motif of Tom20 recognition is shown in the box where Greek letters represent different types of amino acids: W, hydrophobic;
s, hydrophilic; b, basic; x, any amino acid. (D) The N-terminal 84 amino acids of RECQL4 are required for its interaction with Tom20. Interactions were carried
out with bound GST-tagged Tom20 and whole cell lysates expressing different FLAG-tagged RECQL4 proteins in HEK293T cells. After washing, the bound
FLAG-tagged proteins were detected by western blotting with anti-FLAG antibody (top). Levels of GST–Tom20 used for interactions are depicted in the bottom
panel. (E) Deletion of the first 84 amino acids causes complete nuclear accumulation of RECQL4. FLAG-tagged wild-type RECQL4 or truncated RECQL4 (D13–
18) or (D84) were expressed in NHFs using limiting amounts of transfected DNA, and whole cell lysates were prepared. Western blots were carried out with either
anti-FLAG and anti-hsp90 antibodies (bottom, left) or with anti-RECQL4 (K6312) and anti-hsp90 antibodies (bottom, right). The level of endogenous RECQL4
(as seen in the vector lane, bottom right) were compared with the transfected RECQL4 constructs. Post-transfection (24 hours) the cells were washed and IF
carried out with anti-FLAG antibody (top). Nuclei were stained with DAPI. The percentage of transfected cells in which RECQL4 was present in both nucleus and
as punctate staining in cytoplasm is indicated. Scale bar: 5 mm. (F) Amino acids 13–18 of RECQL4 fused to EGFP localized predominantly to the mitochondria.
Amino acids 13–18 of RECQL4 were fused in frame to EGFP and transiently transfected into AG05013 cells. In parallel control transfections were done with
EGFP alone. Cells were fixed after Mitotracker Red CMXRos staining. The percentage of transfected cells showing EGFP colocalization with Mitotracker Red is
indicated. Scale bar: 5 mm.
Journal of Cell Science 125 (10)2516
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
demonstrated compromised mtDNA replication compared with
NHF r cells (Fig. 6D).
To elucidate, in more mechanistic detail, the effect of RECQL4
on mtDNA replication, a new cell line was generated using
AG05013, namely AG05013 RECQL4 (D84) clones 3, 4 and 5 (all
of which expressed RECQL4 at the same level without the N-
terminal 84 amino acid; supplementary material Fig. S11A). All
AG05013 RECQL4 (D84) clones were exclusively nuclear
(supplementary material Fig. S11B, and data not shown). In
RECQL4 (D84) cells only background BrdU staining in the
cytoplasm was observed after de novo mtDNA replication. The
extent of BrdU–PolcA colocalization after the initiation of de novo
mtDNA replication was decreased at all the times examined in
AG05013 RECQL4 (D84) cells (compared with AG05013
AcGFP–RECQL4 clone 1 cells), indicating that the localization
of RECQL4 to the mitochondria was essential for the process
(Fig. 6E; supplementary material Fig. S11C). Clonogenic assays
with AG05013 RECQL4 (D84) cells indicated that the nuclear
localization of RECQL4 could not rescue the high sensitivity of
RTS fibroblasts to camptochecin and neocarzinostatin, especially
at higher concentrations of the drug (supplementary material Fig.
S1B). The lack of mitochondrial localization of RECQL4 caused
the accumulation of p53 in the nucleus in the majority of AG05013
RECQL4 (D84) cells (Fig. 5B). However, in a minority of
Fig. 5. Rescue of RTS cells with wild-type RECQL4 leads to depletion of p53 and p21. (A) Re-expression of AcGFP–RECQL4 (1–1208) in AG05013 cells
leads to mitochondrial localization of the helicase. Complementation of AG05013 cells with AcGFP–RECQL4 (1–1208) leads to the generation of AG05013
AcGFP–RECQL4 (1–1208) clone 1. AcGFP–RECQL4 visualization was carried out after staining the cells with Mitotracker Red. Percentage of cells showing
colocalization of EGFP and Mitotracker Red is indicated. Scale bar: 5 mm. (B) p53 localizes to the mitochondria in AG05013 AcGFP–RECQL4 (1–1208) clone 1
cells. AG05013, AG05013 AcGFP RECQL4 (1–1208) clone 1 and AG05013 AcGFP RECQL4 (D84) clone 5 cells were stained for p53 (SIG-3520–1000)
and subsequently AcGFP and p53 were visualized. Nuclei were stained with DAPI. Percentage of cells showing EGFP colocalization with p53 in the mitochondria
is indicated. Scale bar: 5 mm. (C,D) Decreased expression levels of nuclear p53 and its downstream targets in AG05013 AcGFP–RECQL4 (1–1208) clone 1 cells.
(C) Western blots using whole cell lysates from untreated AG05013 and AG05013 AcGFP RECQL4 (1–1208) clone 1 cells. Antibodies used were: RECQL4
(K6312), p53 (sc-126), Bax, p21, phosphorylated p53 Ser46 and actin. (D) Same as C except that IF was carried out on untreated AG05013 AcGFP–RECQL4
(1–1208) clone 1 cells with p53 (sc-126) and p21 (stained with Cy5-conjugated secondary antibody and represented in monochrome) antibodies and observed
using an epifluorescence microscope at 406magnification. Nuclei were stained with DAPI. Scale bar: 5 mm. Quantification of the IF is represented on the right as
a percentage of p53-positive cells with p21 upregulation. Values are means 6 s.d.
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RECQL4 (D84) cells, p53 was still mitochondrial. This indicated
that mechanisms not mediated by RECQL4 could also lead to p53
accumulation in the mitochondria. The extent of activation of p53
in RECQL4 (D84) cells (as determined by phosphorylation of p53
Ser46, and p21 accumulation) was equivalent to that in AG05013
cells (supplementary material Fig. S11D).
Mitochondrial p53 is known to be involved in enhancing the
accuracy of mtDNA synthesis (Bakhanashvili et al., 2008) and
DNA repair (de Souza-Pinto et al., 2004; Wong et al., 2009). p53
in the mitochondria interacts with mtSSB (Wong et al., 2009) and
has been postulated to enhance DNA replication function of Polc
(Achanta et al., 2005). Hence we wanted to determine the
Fig. 6. RECQL4 affects mitochondrial replication in vivo. (A,B) Absence of RECQL4 reduces the incorporation of BrdU during mitochondrial replication in
(A) NHF shControl and NHF shRECQL4 and (B) NHF and AG05013 cells. Cells are grown in presence of BrdU for 24 hours. The isolated mtDNA was digested
with NheI and stained with ethidium bromide (EtBr; left). The extent of BrdU incorporation was determined by southwestern analysis using anti-BrdU (ab1893)
antibody (middle) for the western analysis. (Right) Quantification of the BrdU incorporation (n53). Values are means 6 s.d. (C,D) RECQL4 affects initiation and
elongation phases of mtDNA replication. After creation of two pairs of cells in r state (NHF shRECQL4 r and NHF shControl r), the cells were washed and
grown in BrdU-containing normal growth medium for 10 minutes, 30 minutes and 60 minutes. (C) After fixation immunofluorescence was carried out with
antibodies against BrdU (RPN202) and PolcA. The image is a representative BrdU-PolcA staining at 10 minutes. Nuclei were stained with DAPI. Scale bar:
5 mm. (D) Quantification of BrdU–PolcA colocalization in the two pairs of r cells (left, NHF shRECQL4 r and NHF shControl r cells, and right, NHF r and
AG03587 r cells). The extent of colocalization is represented as the colocalization factor (details in Materials and Methods). Values are means 6 s.d. (E) The
extent of BrdU–PolcA colocalization after de novo mtDNA replication in AG05013 r, AG05013 AcGFP–RECQL4 (1–1208) clone 1 and AG05013 AcGFP–
RECQL4 (D84) clone 5 r cells. Values are means 6 s.d.
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inter-regulation, if any, between p53 and RECQL4 during the
initiation and elongation phases of mtDNA replication in vivo.
For this purpose we carried out the above assay in two cell line
pairs: (1) NHF r and AG03587 r cells; and (2) NHF shControl r
and NHF shRECQL4 r cells. Lack of RECQL4 drastically
affected the recruitment and maintenance of p53 at the sites of
mtDNA initiation and elongation (Fig. 7A,B, and data not
shown). However, the lack of p53 in NHF E6 r cells did not
affect the localization of RECQL4 to the sites of de novo mtDNA
replication (Fig. 7C,D). Therefore, RECQL4 is required to
transport p53 to the mitochondria and its (i.e. p53) subsequent
recruitment onto the mtDNA.
Discussion
p53 has important functions in the cytoplasm and specifically in
mitochondria (reviewed by Galluzzi et al., 2011; Green and
Kroemer, 2009). It has been demonstrated that under a variety of
apoptotic stimuli, a fraction of p53 translocates rapidly to the
mitochondria. Mdm2-mediated monoubiquitylation of p53
promotes its translocation to the mitochondria where it
subsequently undergoes deubiquitylation, thereby generating
the active mitochondrial p53 capable of acting in the apoptotic
pathway (Marchenko et al., 2000). Mitochondrial p53 is known
to also be involved in enhancing the accuracy of mtDNA
synthesis (Bakhanashvili et al., 2008) and DNA repair (de
Souza-Pinto et al., 2004; Wong et al., 2009). p53 in the
mitochondria interacts with mtSSB (Wong et al., 2009) and has
also been postulated to enhance the DNA replication function of
Polc (Achanta et al., 2005). The cytoplasmic pool of p53 has
been shown to function in energy metabolism, act as an anti-
oxidant and inhibit autophagy, reticulophagy and mitophagy
(Green and Kroemer, 2009; Tasdemir et al., 2008). The above
p53 functions in the mitochondria occur in the absence of any
external stress, indicating that a basal level of p53 is
constitutively present in the mitochondria (Mahyar-Roemer
et al., 2004).
However, an unanswered question remains: how is p53
translocated to mitochondria in untreated cells? In this report,
we have provided evidence that in untreated cells, a fraction of
p53 interacted with RECQL4 (thereby masking the strong NLS of
p53 and also its own NLS; summarized in Fig. 3A). Under these
conditions RECQL4 utilizes its own MLS in the N-terminal
region (Fig. 4) to accumulate in the mitochondria along with the
complexed p53 (Fig. 2D–F; supplementary material Fig. S5B,C).
Fig. 7. (A,B) Lack of RECQL4 affects p53 recruitment to the sites of mtDNA replication. (A) After creation of two pairs of cells in r state (NHF r and
AG03587 r), the cells were washed and grown in BrdU-containing normal growth medium for 10 minutes, 30 minutes and 60 minutes. After fixation of the cells,
immunofluorescence was carried out with antibodies against BrdU (RPN202) and p53 (SIG-3520–1000). The image is a representative BrdU–p53 staining at
10 minutes. Nuclei were stained with DAPI. Scale bar: 5 mm. (B) Quantification of BrdU–p53 colocalization in NHF r and AG03587 r cells. Extent of
colocalization has been represented as the colocalization factor. Values are means 6 s.d. (C,D) Lack of p53 does not affect RECQL4 localization during mtDNA
replication. After creation of two pairs of cells in r state (NHF r and NHF E6 r), the cells were washed and grown in BrdU-containing normal growth medium for
10 minutes, 30 minutes and 60 minutes. (C) After fixation, immunofluorescence was carried out with antibodies against BrdU (RPN202) and RECQL4 (sc-
16924). The image is a representative BrdU–RECQL4 staining at 10 minutes. Nuclei were stained with DAPI. Scale bar: 5 mm. (D) Quantification of BrdU–
RECQL4 colocalization in NHF r and NHF E6 r cells. Extent of colocalization is represented as the colocalization factor. Values are means 6 s.d.
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We propose that RECQL4 acts as a regulator of the
mitochondrial localization of p53, thereby functioning in a
similar manner to mitochondrial hsp70 and hsp90, known to
transport proteins to the mitochondria (Deshaies et al., 1988;
Young et al., 2003). Lack of RECQL4 (either in RTS cells or in
cells with a genetically defined isogenic background) led to
accumulation of spontaneous DNA damage in the nucleus (as
detected by formation of 53BP1 foci; supplementary material
Fig. S3A,B). The spontaneous DNA damage activated ATM and/
or ATR, which phosphorylated and stabilized p53 in RTS cells
(Fig. 1D; supplementary material Fig. S3C). In NHFs, RECQL4–
p53 interaction was disrupted in the presence of DNA damage
(supplementary material Fig. S8C–F). Hence, in either case (i.e
the lack of RECQL4 and/or after DNA damage) p53 utilizes its
own NLS and accumulates directly in the nucleus, thereby
carrying out its functions as a transcription factor (Fig. 1;
supplementary material Fig. S1A, Fig. S2). Complementation
experiments involving re-expression of wild-type RECQL4 in
RTS cells (Fig. 5) validated the hypothesis that full-length
RECQL4 acts as an important component in the regulatory circuit
of p53 in untreated cells. Consequently in cells expressing
RECQL4 (D84) mutant where RECQL4 expression is nuclear,
the majority of the p53 accumulated in the nucleus also, as it was
no longer able to accumulate in the mitochondria (Fig. 5B).
Interestingly, the nuclear p53 in RECQL4 (D84) cells was
transcriptionally active (supplementary material Fig. S11D). This
also possibly accounts for the high sensitivity of the RECQL4
(D84) cells to multiple forms of DNA damage (supplementary
material Fig. S1B).
Earlier studies had indicated that a substantial fraction of
endogenous RECQL4 was located in the cytoplasm (Petkovic
et al., 2005; Werner et al., 2006; Yin et al., 2004). It had been
proposed that five lysine residues in RECQL4 could be
acetylated by p300. Acetylation of RECQL4 by p300 in vivo
led to its cytoplasmic localization (Dietschy et al., 2009). All the
predicted lysine residues are within the 270–400 amino acid
stretch of RECQL4 that interact with p53 (supplementary
material Fig. S7H). Future research might indicate whether
acetylation of RECQL4 in vivo regulates its binding to p53 and
consequently its accumulation in the mitochondria.
The role of RECQL4 in nuclear DNA replication (Matsuno
et al., 2006; Sangrithi et al., 2005; Xu et al., 2009) coupled with
the colocalization of RECQL4 and the mtDNA (Fig. 2F;
supplementary material Fig. S5B) provided a clue to the
function of RECQL4 during mtDNA replication. The
colocalization of RECQL4 with PolcA throughout the cell
cycle (Fig. 3E) is in agreement with the known fact that mtDNA
replication occurs throughout the cell cycle (Magnusson et al.,
2003). De novo mtDNA replication indicated that lack of
RECQL4 led to a decrease in the extent of colocalization
between BrdU (i.e the sites of new DNA synthesis) and PolcA
(Fig. 6C,D). This suggests that mtDNA replication is hampered
in the absence of RECQL4. Indeed southwestern analysis
indicated that mtDNA replication was lower in RTS cells and
in isogenic cells in which RECQL4 was genetically ablated
(Fig. 6A,B). Hence the role of RECQL4 in de novo mtDNA
replication was dependent on its mitochondrial localization
(Fig. 6E; supplementary material Fig. S11C). It was also
observed that RECQL4 was essential for the accumulation of
p53 at the sites of de novo mtDNA replication as stained by BrdU
(Fig. 7A,B). p53 has known functions during mtDNA replication
(Achanta et al., 2005; Bakhanashvili et al., 2008; Wong et al.,
2009). Therefore, by controlling the recruitment of p53 to the
sites of de novo mtDNA replication, RECQL4 might also be
regulating the mitochondrial functions of p53. This role of
RECQL4 is similar to that of another member of the RecQ family
of helicases, BLM helicase. BLM is an anti-recombinogenic
protein that has been shown to be involved in the transport of p53
to sites of DNA damage in the nucleus (Sengupta et al., 2003).
Given the important roles of both p53 and RECQL4 in the
nucleus during DNA replication, repair and recombination
(Matsuno et al., 2006; Petkovic et al., 2005; Sangrithi et al.,
2005; Sengupta and Harris, 2005), it is possible that the
mitochondrial and nuclear functions of these two tumor
suppressors are altered during neoplastic transformation. This
study provides insight into the specific roles of RECQL4
helicase, which are dependent on its localization to the
mitochondria. These include the effect of RECQL4 on de novo
mtDNA replication (Fig. 6E; supplementary material Fig. S11C),
sensitivity to DNA damaging drugs (supplementary material Fig.
S1B) and the accumulation of p53 in the mitochondria (Fig. 5B).
Future studies to determine the interplay of RECQL4 and p53
between the two subcellular compartments might provide
important insight into the progression of cancer and other
abnormalities seen in RTS patients.
Materials and methods
Antibodies
Anti-RECQL4: mouse monoclonal K6312 (Kawabe et al., 2000); goat polyclonal
sc-16924 (Santa Cruz). Anti-p53: mouse monoclonal sc-126 (Santa Cruz), rabbit
polyclonal SIG-3520-1000 (Covance). Anti-FLAG antibody: mouse monoclonal
F1804 (Sigma). Anti-cytochrome c: rabbit polyclonal sc-7159 (Santa Cruz). Anti-
GST: rabbit polyclonal 71-7500 (Invitrogen). Anti-GFP: rabbit polyclonal 632460
(Takara). Anti-hsp90: rabbit polyclonal sc-7947 (Santa Cruz). Anti-p21: mouse
monoclonal sc-397 (Santa Cruz). Anti-MDM2: mouse monoclonal ab16895
(Abcam). Phosphorylated p53 Ser15: #9284 rabbit polyclonal (Cell Signaling).
Phosphorylated p53 Ser46: rabbit monoclonal ab76242 (Abcam). Anti-Bax: rabbit
polyclonal sc-493 (Santa Cruz). Anti-Bcl-2: mouse monoclonal 100 (Santa Cruz).
Anti-BrdU: mouse monoclonal RPN202 (GE Healthcare) and sheep polyclonal
ab1893 (Abcam). Anti-TBP: mouse monoclonal sc-421 (Santa Cruz). Anti-actin:
sc-8432 (Santa Cruz). Anti-53BP1: mouse monoclonal 612523 (BD Pharmingen).
Anti-PolcA: rabbit polyclonal sc-48815 (Santa Cruz). Anti-PCNA: mouse
monoclonal sc-56 (Santa Cruz). All secondary antibodies were all purchased
from Jackson ImmunoResearch.
Recombinants
GST-p53 deletion constructs (Sengupta and Wasylyk, 2001); p53-EGFP-C1 (1–
393) (a gift from Tyler Jacks, Koch Institute of Integrative Cancer Research, MA,
USA). pcDNA3.1 p53 (1–393) (a gift from Ronald Hay; Welcome Trust Centre for
Gene Regulation and Expression, Dundee, UK). pcDNA3-FLAG-RECQL4 (1–
1208), pcDNA3-FLAG-RECQL4 (D84), pcDNA3-FLAG-RECQL4 (D404),
pcDNA3-FLAG-RECQL4 (1–459) were obtained by cloning RECQL4
fragments between the NheI and XhoI sites of the FLAG-tagged pcDNA3
construct. pLVX-AcGFP-N1-RECQL4 (1–1208) and pLVX-AcGFP-N1-RECQL4
(D84) were obtained by cloning the respective RECQL4 fragments between the
XhoI and EcoRI sites of the pLVX-AcGFP-N1 construct. pcDNA3.1 hygro (+)-
EGFP-RECQL4 (13–18) was obtained by cloning the RECQL4 amino acids in
frame with EGFP into the AflII–BamHI sites of pcDNA3.1 hygro(+) vector. GST-
RECQL4 constructs were obtained by cloning the 1–459 fragment into the
BamHI–EcoR1 sites and 460–868, 869–1208, 1–150, 151–300, 301–459, 151–459,
180–459, 210–459, 240–459, 270–459, 151–430, 151–400, (151–370), 151–340
and 270–400 fragments into the EcoR1–XhoI sites of the pGEX4T-1 vector.
pcDNA3.1 hygro(+)-FLAG-PolcA obtained by cloning the PCR product into the
NheI–NotI sites of the vector, using pBacPAK-PolcA (a gift from Maria
Falkenberg, University of Gothenburg, Sweden) as the template. pSilencer2.1-
U6 hygro-RECQL4 was obtained by cloning the 19-nucleotide RECQL4 siRNA
sequence (59-GCTTCGAGAGCTACGTGCA-39) into the BamHI–HindIII sites of
pSilencer2.1-U6 hygro (Ambion). The corresponding siRNA for RECQL4
having the same sequence and p53 siRNA having the sequence (59-
GACTCCAGTGGTAATCTAC-39) were synthesized from Dharamacon. ON-
TARGETplus non-targeting siRNA #1 siRNA (Dharmacon) was used as the
control siRNA in all experiments. pGEX-6P-1-ratTom20 (59–126) was a gift from
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Daisuke Kohda, Kyushu University, Japan. pcDNA3-FLAG-RECQL4 (D13–18)
was obtained by site directed mutagenesis.
Cell culture conditions
Immortalized normal human fibroblasts (NHFs, GM07532) and NHF E6 cells were
maintained as described previously (Sengupta et al., 2003). GM08402 and MRC-5
were obtained from Coriell Cell Repositories and ViroMED Laboratories,
respectively. Primary RTS fibroblasts (Kitao et al., 1999b) were obtained either
from Coriell Cell Repositories (AG03587, AG05013 and AG05139) or from the
Mayo Clinic (L9552914-J, B1865425K and D8903644-K). All the RTS fibroblasts
used (AG03587, AG05013, AG05139, L9552914-J, B1865425K and D8903644-
K) were subsequently immortalized by induction of telomerase into the cells by
standard procedures. By Genechip PCR analysis and functional assays, p53 was
found to be wild-type in the cells from RTS patients (AG03587, AG05013,
AG05139, B1865425K and D8903644-K), whereas it was mutated in L9552914-J
cells (data not shown). Lentiviruses carrying AcGFP-N1-RECQL4 (1–1208) and
AcGFP-N1-RECQL4 (D84) were prepared by cotransfecting Lenti-X HT
packaging mix with the corresponding plasmid into the Lenti-XTM 293T cell
line using the Lenti-X HT packaging mix (Takara). AG05013 cells were
transduced with recombinant lentiviruses and cells were selected with
puromycin (0.5 mg/ml) for 10 days. The clones obtained were analyzed by
western blotting. NHF shRECQL4 and NHF shControl cells were prepared by
stably integrating pSilencer2.1-U6 hygro-RECQL4 and pSilencer2.1-U6 hygro,
respectively, into NHF cells. Clones were selected with hygromycin (300 mg/ml)
for 7 days and analyzed by western blotting.
The r0 cells were created by culturing the parental cells for 14 days in presence
of 50 ng/ml ethidium bromide, 50 mg/ml uridine and 2 mmol/l pyruvate. The
medium was changed every third day and fresh supplements were added. On the
14th day, the levels of the nuclear genome encoded cytochrome b were analyzed
by PCR to determine the extent of the depletion of mitochondrial DNA (mtDNA).
If complete depletion of mtDNA was observed, the cells were classified as r0 cells.
The r cells used for de novo replication assays were prepared by following exactly
the above process except that the cells were treated with the supplements (ethidium
bromide, uridine and pyruvate) for only 10–12 days, when depletion of mtDNA
was not complete (as observed by cytochrome b amplification). The resulting cells
were classified as r cells.
For immunofluorescence analysis cells were treated with BrdU (15 mM) for 3
hours or leptomycin B (5 ng/ml) for 4 hours. Cells were treated with N-
acetylcysteine (20 mM) for 1 hour. For de novo replication assays the r cells were
treated with BrdU (15 mM) for the indicated time intervals, and then fixed. For
double thymidine block, NHFs was treated with thymidine (2.5 mM) for 17 hours,
washed, released into thymidine-free medium for 12 hours and then re-treated with
thymidine (2.5 mM) for 17 hours. This treatment regime blocked the cells at the
G1–S boundary (taken as the 0 hours time point). The final concentrations of drugs
used for the DNA damage experiments were: camptothecin (0.5 ng/ml; Sigma),
etoposide (2ng/ml; Sigma) and neocarzinostatin (0.2 ng/ml; NCI, NIH). All
transient transfections were carried out with Lipofectamine 2000, using
Optimem (Invitrogen) as the transfection medium. Mitochondria were stained
using the fluorescent dye Mitotracker Red CMXRos (200 nM; Invitrogen). Live
cells were incubated with of this dye for 30 minutes. The cells were subsequently
washed, fixed and then analyzed. For long-term colony formation assays the cells
were exposed for 6 hours with the indicated concentrations of the respective drugs.
The cells were extensively washed and the culture continued for the next 14–21
days, after which the clones formed were stained with Giemsa.
Microscopy techniques
Confocal microscopy was done according to published protocols (Sengupta et al.,
2003). Cells were fixed initially with either 100% ethanol, 100% methanol,
methanol:acetone (1:1), 4% paraformaldehyde or 3.7% formaldehyde. All
fixation conditions gave similar results. Subsequently freshly prepared 4%
paraformaldehyde fixation was used for all the immunofluorescence staining in
which antibodies were used. For fixation of cells treated with Mitotracker Red,
3.7% formaldehyde was used in the medium. Subsequent to fixation, the cells were
rinsed three times with 16 PBS, twice treated with 0.1% Triton X-100 for
5 minutes each, washed with 16PBS with 0.5% Tween 20 and blocked overnight
with 10% normal chicken serum. Subsequently the staining was carried out with
the indicated antibodies at 37 C˚, for 1 hour in a humidified chamber. Incubation
with secondary antibody was also carried out under similar conditions.
Adequate controls, such as use of the corresponding IgG or not using secondary
antibody, were always included. At least 150 cells were analyzed for all
immunofluorescence experiments. The slides were analyzed using a Zeiss Axio
Imager M1 epifluorescence microscope with 1006/1.4 NA oil, 636/1.25 NA oil or
406/0.75 NA objective or a Zeiss 510 Meta system with 636/1.4 NA oil
immersion or 406/0.95 NA Corr objective. The laser lines used were argon 458/
477/488/514 nm (for FITC), DPSS 561 nm (for Texas Red and Mitotracker dyes),
HeNe 633 nm (for Cy5) and a Chameleon Ultra autotunable femtosecond laser
with a tuning range 690–1050 nm (for DAPI). LSM5 software (Carl Zeiss) was
used for image acquisition. Details of each quantification are indicated in the
respective figure legends. In specific cases quantification has also been defined by
colocalization factor. Colocalization factor is defined as [(fraction of cells having
colocalization)6 (fraction of foci colocalized per cell)].
Southwestern analysis
Cells, cultured in 86175 cm tissue culture flasks, were grown to 60% confluency
and incubated for 24 hours with BrdU (15 mM). Mitochondria were isolated by
differential centrifugation. Isolated mitochondria was lysed in lysis buffer (50 mM
Tris-HCl, pH 7.5, 1 mM EDTA, 0.55 Tween-20) and treated with proteinase K.
Proteins were removed by phenol–chloroform–isoamyl alcohol extraction and the
isolated mtDNA was digested with NheI (1 mg was used per sample) for
40 minutes at 37 C˚. NheI cuts the mtDNA at one site. The digested DNA was run
on a 1% agarose gel, stained with ethidium bromide or transferred onto a
nitrocellulose membrane and probed with anti-BrdU antibody.
Genomic PCR
Genomic DNA was isolated by standard processes. The primers were: 59-CTAC-
AATGAGCTGCGTGTGGC-39 and 59-CAGGTCCAGACGCAGGATGGC-39 for
actin, and 59-GGCTTACTTCTCTTCATTCTCTCCT-39 and 59-GGTTGTCCT-
CCAATTCATGTTA-39 for cytochrome B.
Expression, purification and interactions of proteins
FLAG-tagged RECQL4 and its mutants were expressed in HEK 293T cells for
interaction studies. GST-tagged proteins were expressed according to standard
protocols in Escherichia coli at 16 C˚ or 18 C˚ and subsequently purified by binding
to glutathione S-Sepharose (GE Healthcare). pcDNA3-FLAG-RECQL4 and
pcDNA3.1-p53 were used for coupled in vitro transcription and translation of
RECQL4 and p53, respectively, using the T7 Quick Coupled Transcription/
Translation System kit (Promega) in the presence of [S35]methionine. GST-bound
target proteins were incubated with the in-vitro-translated interacting partner (p53
or RECQL4) for 4 hour at 4 C˚ with constant inversion. Interaction was assayed by
autoradiography. For interactions involving GST-tagged bound proteins and
FLAG-tagged interacting partners, the two components were mixed overnight in
an end-to-end rocker. The bound proteins were then centrifuged, washed and
analyzed by western blotting. The mitochondrial fraction was isolated as
previously described (Achanta et al., 2005). Cytoplasmic and nuclear extracts
from cells were made using NE-PER Nuclear and Cytoplasmic Extraction Reagent
(Pierce). For preparation of whole cell lysates the cells were lysed in a modified
RIPA buffer [1 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% sodium deoxycholate,
0.1% SDS, 1 mM phenylmethylsulfonylfluoride (PMSF) and protease inhibitors].
For endogenous interactions, immunoprecipitations (IPs) were carried out with
whole cell extracts using standard protocols (1 mg/IP, 2 mg antibody/IP).
Web-based tools
Four web-based tools: Target P (Emanuelsson et al., 2007), PSORT (Nakai and
Horton, 1999), MitoProt (Claros and Vincens, 1996) and iPSORT (Bannai et al.,
2002) were used to predict the MLS in RECQL4.
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